propiverine has been researched along with Parkinson Disease, Secondary in 2 studies
propiverine: anticholinergic used for overactive bladder syndrome
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously reported the induction of catalepsy by amiodarone, aprindine and procaine, which possess a diethylaminomethyl moiety and demonstrated selective blockade of dopamine D2 receptors by these drugs in mice." | 1.31 | Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice. ( Hattori, F; Inoue, N; Matsui, A; Matsuo, H; Nasu, R; Ohtani, H; Sawada, Y; Takanaga, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugiyama, Y | 1 |
| Matsuo, H | 1 |
| Matsui, A | 1 |
| Nasu, R | 1 |
| Takanaga, H | 1 |
| Inoue, N | 1 |
| Hattori, F | 1 |
| Ohtani, H | 1 |
| Sawada, Y | 1 |
2 other studies available for propiverine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[Parkinsonism induced by propiverine hydrochloride--report of 3 cases].
Topics: Aged; Aged, 80 and over; Benzilates; Cholinergic Antagonists; Gait; Humans; Male; Parasympatholytics | 1997 |
Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice.
Topics: Animals; Antitussive Agents; Benzilates; Catalepsy; Cholinergic Antagonists; Cyclopentanes; Male; Ma | 2000 |